Objective: Patients aged ≥65 years requiring surgery for soft-tissue sarcoma are a concern in an aging society. We aimed to reveal the association of clinical/geriatric factors with survival period or postoperative events in such patients who underwent surgery. Methods: We enrolled patients aged ≥65 years who underwent surgery for localized soft-tissue sarcoma at five institutions. We retrospectively collected clinical/geriatric factors and laboratory data, and analyzed their association with outcomes using univariate and multivariate analyses. Results: Among the 202 patients included, mean age at presentation was 73 years. Surgical margin was R0 in 139 patients (69%). The Eastern Cooperative Oncology Group performance status was ≥2 in 15 (7%). Thirty patients (15%) showed thinness (body mass index <18.49 kg/cm 2 ). Highsensitivity-modified Glasgow prognostic score ≥1 was seen in 52 patients (26%). Multivariate analysis showed that R1 surgical margin was significantly correlated with poor sarcoma-specific survival (hazard ratio for R1 vs. R0, 3.17; P = 0.001) and event-free survival (hazard ratio for R1 vs. R0, 2.56; P < 0.001). Higher Eastern Cooperative Oncology Group performance status was significantly associated with poor sarcoma-specific survival (hazard ratio for ≥2 vs. 0 or 1, 2.15; P = 0.038), and higher sensitivity-modified Glasgow prognostic score was significantly associated with poor event-free survival (hazard ratio for ≥1 vs. 0, 1.74; P = 0.046). Severe thinness (body mass index <16.00) was a risk factor for postoperative events (odds ratio for body mass index <16.00 vs. ≥16.00, 8.15, P = 0.010). Conclusions: Negative surgical margin was associated with better survival. Coexisting conditions had an impact on outcomes in elderly soft-tissue sarcoma patients.
Introduction
Soft-tissue sarcoma (STS) is a rare malignancy originating from mesenchymal tissues. STS can occur at any anatomic site and at any age, and frequently shows rapid growth. Complete resection with a negative surgical margin is a potentially curative treatment option for STS. Although tumor resection with negative microscopic margins (R0 resection) is the goal, aggressive approach is frequently necessary in locally advanced tumors (1) .
Individuals aged ≥65 years comprise one-third of the Japanese population, and this is the highest percentage in the world (2) (3) (4) . Consequently, the number of elderly patients with STS has been increasing in Japan (5) . Surgeons might hesitate to treat elderly patients as intensively as younger patients because they sometimes have vulnerabilities, such as decreased performance status and several comorbidities, which may be associated with postoperative complications or death. Recently, more intensive and comprehensive evaluation, such as comprehensive geriatric assessment (CGA), has been recommended for elderly patients who are scheduled to undergo surgery for cancer to evaluate the vulnerabilities accurately (6, 7) . CGA includes many geriatric factors such as cognitive ability, depression, comorbidities, functional status, nutritional status, and polypharmacy, and these factors have been shown to predict prognostic and surgical outcomes (6) (7) (8) (9) .
Although several studies have described the therapeutic outcomes in elderly STS patients who underwent surgery (10) (11) (12) (13) (14) (15) , there have been no previous reports comprehensively evaluating the association between these geriatric factors and treatment outcomes. Intensive analysis involving these geriatric factors would help to provide better strategies for evaluation and intervention in these patients.
Therefore, in the present study, we aimed to clarify the association between clinical/geriatric factors in CGA and surgical and prognostic outcomes in the elderly patients with localized STS who underwent surgery.
Patients and methods
This was retrospective observational study at three cancer centers and two university hospitals in Japan (Higashi-nihon Orthopaedic and Pediatric Sarcoma Group; HOPES). We enrolled patients aged ≥65 years who underwent surgery for localized STS between 2004 and 2008 in these hospitals. We excluded patients with intermediate tumors according to the WHO classification (16) , including atypical lipomatous tumor (well-differentiated liposarcoma), desmoid-type fibromatosis, solitary fibrous tumor and those with metastasis at initial presentation. The surgical indications for patients with STS were judged in each hospital considering the life expectancy and general health status based on the age and comorbidities. Adjuvant chemotherapy was delivered in patients considered to be high risk of metastasis and expected to be tolerable based on the age and comorbidities. Radiation therapy was indicated in patients considered to be high risk of local recurrence because of close or positive surgical margin.
We collected the following data for each patient from retrospective chart reviews: age; sex; size, depth and location of the tumor; Union for International Cancer Control TNM classification system version 7 (UICC stage); histological grade (low or high) and diagnosis; laboratory data before surgery (albumin and C-reactive protein, CRP); treatment details; postoperative events and survival time. Postoperative events included wound complications, such as surgicalsite infection or delayed wound healing; respiratory complications; cardiovascular, abdominal and cerebrovascular events; acute renal failure or death within 30 days postoperatively. The microscopic surgical margin was histologically determined on resected specimens and was classified as R0 (no tumor cells microscopically seen), R1 (tumor cells microscopically seen) or R2 (gross examination showed tumor tissue at the margin).
The following geriatric factors were collected according to previous reports: the Eastern Cooperative Oncology Group performance status (ECOG PS), body mass index (BMI), number of medications being administered and comorbidities (6) . BMI was divided into categories according to the WHO classification (17) . The Charlson comorbidity index (CCI) was used to evaluate the extent of preoperative comorbidities (18) . The score for a malignant tumor was determined as 2 in CCI; therefore, patients were divided into the following groups: CCI = 2 (without comorbidities) and CCI ≥3 (with comorbidities). Albumin and CRP were evaluated using highsensitivity-modified Glasgow prognostic score (Hs-mGPS) (19) . Patients with both hypoalbuminemia (<3.5 g/dl) and elevated CRP level (>0.3 mg/dl) were allocated a score of 2, which indicated worse prognosis. Those who had only an elevated CRP level were allocated a score of 1. The remaining patients were allocated a score of 0. The endpoints were disease progression, recurrence, death and occurrence of postoperative events. This study was approved by the Institutional Review Board of each participating hospital.
All time-to-event endpoints were calculated using the KaplanMeier method. Overall survival (OS) was defined as the time period from the date of surgery to that of death from any cause or the last follow-up for survivors. Sarcoma-specific survival (SSS) was defined as the time period from the date of surgery to that of death from STS or the last follow-up for survivors. Event-free survival (EFS) was defined as the time period from the date of surgery to that of disease progression, recurrence, death from any cause or the last follow-up for patients without events. Potential prognostic factors were identified by univariate analysis using the log-rank test. Independent prognostic factors were evaluated using the Cox proportional hazards regression model. Predictors of postoperative complications or R1 surgical margin were identified by the chisquared test, and variables with a P value of <0.05 were included in the multivariate logistic analysis. Differences at P values of <0.05 were considered significant. Statistical analyses were performed using SPSS version 22.0 (IBM, Armonk, NY, USA).
Results

Patients' clinical/geriatric factors, Hs-mGPS and treatment
The mean follow-up time was 58 months (95% confidence interval [CI], 52-62 months). The baseline clinical characteristics of the patients and treatment are listed in Table 1 . The mean patient age was 73 years. Surgical margin was R0 in 139 patients and R1 in 56. Only seven patients received adjuvant chemotherapy. We showed geriatric factors of seven patients in Supplementary Table 1 . Table 2 shows the geriatric factors and Hs-mGPS. ECOG PS was ≥2 in 15 patients. BMI <18.49 kg/m 2 (thinness) was recorded in 30 patients. A history of cancer was observed in 17, and history of heart-related comorbidities (acute myocardial infarction = 6 or chronic heart failure = 1) were observed in 7. CCI score was ≥3 in 55 patients, and Hs-mGPS was ≥1 in 52 patients.
Outcomes and prognostic factors
The 5-year OS and SSS rates were 78.1% (95% CI, 70.9-83.7%) and 79.0% (95% CI, 71.8-84.6%), respectively. Overall death and disease-specific death occurred in 45 patients and 40 patients, respectively. Five patients died because of other causes unrelated to sarcoma. We showed geriatric factors of five patients in Supplementary  Table 2 . Local recurrence, metastatic recurrence and overall recurrence occurred in 54 (27%), 58 (29%) and 86 patients (43%), respectively. The 5-year EFS rate was 71.3%. The univariate and multivariate association between various factors and SSS were shown in Table 3 . The univariate analyses showed that tumor size, UICC stage, surgical margin and ECOG PS were significantly correlated with SSS. The multivariate Cox proportional hazards model showed that the SSS was significantly correlated with UICC stage (hazard ratio [HR] for III vs. II or I, 2.81; 95% CI, 1.30-6.06; P = 0.009), surgical margin (HR for R1 vs. R0, 3.17; 95% CI, 1.63-6.17; P = 0.001) and ECOG PS (HR for 2 vs. 0 or 1, 2.15; 95% CI, 1.04-4.44; P = 0.038).
The univariate and multivariate association between various factors and EFS were shown in Table 4 . In the multivariate analysis, EFS was significantly correlated with surgical margin (HR for R1 vs. R0, 2.56; 95% CI, 1.53-4.29; P < 0.001), Hs-mGPS (HR for ≥1 vs. 0, 1.74; 95% CI, 1.01-2.99; P = 0.046) and ECOG PS (HR for 2 vs. 0 or 1, 1.95; 95% CI, 1.05-3.60; P = 0.034).
Because it is important to clearly show the role of surgical margin in the treatment of STS and for decision-making of the aggressiveness of the surgery, especially in the elderly patients, we performed additional analyses focusing on the surgical margin. Kaplan-Meier curves for SSS, EFS, metastasis-free survival (MFS) and local recurrence-free survival (LRFS) (Fig. 1a-d ) demonstrated that surgical margin had a significant impact on survival, suggesting the importance of the margin-negative approach.
Postoperative events and risk factors
Postoperative events occurred in 34 (16.8%) patients. These included superficial or deep surgical-site infection in 16 (7.9%) patients, delayed wound healing in 11 (5.4%), delirium in 4 (2.0%), acute renal failure in 1 (0.5%), venous thromboembolism in 1 (0.5%), ileus in 1 (0.5%) and death from other cause unrelated to 
Discussion
The proportion of elderly patients requiring surgery for STS has been steadily increasing owing to an aging society in Japan (4).
To reveal the practical treatment strategy for localized elderly STS, we collected data on clinical/geriatric factors, and analyzed the association of these factors and outcomes. Higher PS was predictor of worse SSS, and higher PS and Hs-mGPS were predictors of worse EFS. Severe thinness (BMI <16.00) was associated with occurrence of postoperative events. Although the role of the surgical margin in the treatment of STS in the elderly has not been clearly defined, we have found the important findings that R0 surgical margin was significantly associated with better SSS and EFS.
The 5-year SSS (79.0%) in the present study was comparable with the previous reports examining the treatment outcome of elderly patients with localized STS who underwent surgery (63-83%) (10, 12, 15) . In our study, only five patients died because of other causes unrelated to sarcoma and this results may indicate the need of curative therapy for elderly patients with STS.
In the present study, PS and Hs-mGPS were significantly associated with survival. Inflammation plays a critical role in tumor progression, and GPS is considered to reflect an ongoing systemic inflammatory response (high CRP) and following protein break down or progressive nutritional decline (hypoalbuminemia) (20) (21) (22) . Therefore, HS-mGPS is considered to reflect tumor aggressiveness, and it has been shown to be a valuable prognostic factor for cancer patients (19, 23) . The present study showed that HS-mGPS could enable the physicians to more accurately estimate the risk of recurrence and stratify patients who need more intensive surgery or adjuvant chemotherapy in elderly patients with STS. PS was reported to be a significant predictor of long-term outcome in metastatic STS and other forms of localized cancer (24, 25) . Patients with PS 0 or 1 can receive more intensive surgery or adjuvant therapy for localized disease than those with PS ≥2. These factors may have had a great influence on survival in our series. The present study is the first to show the significant impact of Hs-mGPS and PS on survival in elderly patients with localized STS, and comprehensive assessment using these data, as well as other geriatric and clinical factors, is recommended.
The rate of postoperative events in our study was 16.8%, with surgical-site infection being the most frequent complication. Although we could not directly compare the rate of postoperative events with previous reports because of differences in collected data, it was almost similar to previously published data (6.1-30%) (4, 9) . Lower BMI was significantly correlated with postoperative events. Our study was consistent with several other studies, which suggested associations between lower BMI and higher postoperative complications in surgery for STS in all ages as well as other cancer-related surgery (26, 27) . Our data emphasize the usefulness of BMI to evaluate the risk of postoperative events for these patients. Lower BMI can probably be caused by malnutrition, which results from cancer bearing status, chronic inflammatory activity and age-associated anorexia (28) .
It remains controversial whether a positive surgical margin or local recurrence affects OS or MFS following STS resection for patients of all age groups and the elderly. Several studies have concluded that a positive surgical margin could directly lead to distant metastasis and decreased survival (29, 30) . In contrast, local recurrence has been suggested to reflect the biological behavior of high-grade tumors; therefore, adequate surgical margin was not a predictor of better prognosis (31, 32) . Moreover, a previous report on elderly STS showed that surgical margin did not correlate with OS (9) . However, our study showed that R1 surgical margin had the strongest impact on worse SSS, EFS, MFS and LRFS in the elderly patients with localized STS. One explanation of the strong association between R1 margin and survival in the present study might be that only 4 (1.9%) patients received adjuvant chemotherapy. Adjuvant chemotherapy for elderly STS tends to be avoided because elderly patients plausibly have vulnerabilities (10, 12) . Because adjuvant chemotherapy could decrease the residual local tumor and microscopic metastasis, it might obscure the effect of R1 margin in the previous reports (10) . Another explanation is high rate of patients with undifferentiated pleomorphic sarcoma or myxofibrosarcoma in our cohort. UPS and myxofibrosarcoma showed tendency to have more positive surgical margin compared with the other histology (30.3% vs. 22.0%). These infiltrative growth tumors were shown to correlate with positive surgical margin or worse prognostic outcomes (33) . From our results, we consider that positive surgical margin could directly lead to distant metastasis and affect survival in the elderly localized STS.
We could not describe any conclusive statement about efficacy of irradiation from our study. In our series, adjuvant radiation therapy was significantly associated with high local recurrence rates (P = 0.003) and worse LRFS (P < 0.001). We considered these results were because adjuvant radiation therapy was performed for patients with high risk of local recurrence.
Our study has several limitations. First, this was a study based on the retrospective review of medical records; thus, some factors may have been under-reported. It might have some selection bias as some elderly patients with severe comorbidities who were unable to undergo surgery were not included in our study. Second, we could not collect data on the other geriatric factors, such as instrumental activity of daily living and frailty scores, which have been reported to be useful predictors of poor outcomes (6) . However, in daily clinical practice, the evaluation of these factors is very difficult to implement for all patients because it is time consuming or requires a specific geriatric unit. The evaluation of the limited clinical data, which we were able to obtain from daily clinical practice, could also contain useful information.
In conclusion, negative surgical margin was associated with the better survival of elderly STS patients. PS or Hs-mGPS could be useful predictors of prognosis. Our data suggest that the preoperative evaluation of BMI is useful. Coexisting conditions affected surgical and prognostic outcomes for elderly STS patients. These association needs to be validated with a larger group in a future study.
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